✦ LIBER ✦

P091 - Tolerance and efficacy of a late retreatment with infliximab in Crohn's disease

✍ Scribed by D. Laharie; E. Chanteloup; K. El Hanafi; C. Subtil; V. de Lédinghen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The tolerance and efficacy of a postpone

✍ D. LAHARIE; E. CHANTELOUP; E. CHABRUN; C. SUBTIL; M. KOWO; K. EL HANAFI; V. DE L 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Efficacy and tolerance of infliximab in

✍ Dr. Thierry Lamireau; Jean-Pierre Cézard; Alain Dabadie; Olivier Goulet; Alain L 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

P185 MEDIUM-TERM EFFICACY OF INFLIXIMAB

✍ T. Molnar; K. Farkas; P. Miheller; Z. Szepes; L. Herszenyi; G. Muzes; F. Nagy; T 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 73 KB

Retreatment and maintenance therapy with

✍ Rodrigo, Luis; Perez-Pariente, Jm.; Cadahia, V.; Fuentes, D.; Nino, P.; Francisc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Efficacy and safety of retreatment with

✍ Paul Rutgeerts; Geert D'Haens; Stephan Targan; Eric Vasiliauskas; Stephen B. Han 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 155 KB

P173 - Efficacy of adalimumab in patient

✍ P. Cordero Ruiz; C. Catro Marquez; V. Mendez Rufian; L. Castro-Laria; á. Caunedo 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 46 KB